TACE-HAIC
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TACE-HAIC, covering 2021-04-23 to 2021-09-22. Get the full timeline:
Most recent: Clinical Trial Update: PD-1 Antibody and Lenvatinib Plus TACE-HAIC for Potential Resectable HCC: a Single-arm, Phase 2 Clinical Trial [Phase 2]